Debunking Biologic Safety Myths in Elderly Psoriasis Patients
Age alone should not disqualify older psoriasis patients from biologics, argues a Dermatology Times analysis dismantling persistent safety myths in geriatric prescribing.
Topic
Shared Decision Making
Topic
Shared Decision Making
Psoriasis Care Redefined: Clear Skin Is No Longer the Sole Endpoint
A new review in Expert Opinion on Biological Therapy argues psoriasis success now spans symptoms, quality of life, preferences, a…
Updated Atopic Dermatitis Guidelines Urge Proactive, Personalized Care
Updated atopic dermatitis guidelines call for proactive, personalized management, framing AD as a chronic disease requiring maint…